Cell therapy manufacturing & gene therapy congress

29 November 2019


Cell therapy manufacturing

Fast track cell, gene and CAR-T commercialization from concept to robust patient-centric delivery at Cell Therapy Manufacturing & Gene Therapy Congress.

That’s right! It’s that time of year again and the Cell Therapy Manufacturing & Gene Therapy Congress team are aiming to help you fast track your cell, gene and CAR-T commercialization from concept right through to robust patient-centric delivery.

Bringing together 400+ leaders and key influencers from pharma and biotech companies this December in Amsterdam, Cell Therapy Manufacturing & Gene Therapy 2019 will share the latest tech, manufacturing and supply chain challenges to revolutionize your clinical and late-stage programs.

Discover everything you need in one place. Move between 5 streams jam-packed with topical talks, benchmarking opportunities and case studies. PLUS you can meet with old and new colleagues for an unrivalled on-site experience. At Cell Therapy Manufacturing & Gene Therapy Congress you can get an all-access pass to the 3 main days of comprehensive content plus an exclusive pre-conference day boasting a host of new topics.

Brand New 2019 Content for this year includes:

Clinical and Early Stage CAR T Cell and Gene Therapy Advances:

  • Push the boundaries of CD19 with solid tumours, combination therapies and safety switches
  • Transition technologies from bench to bedside: CRISPR, Exosomes and more…
  • Understand how to build a sustainable process early on for optimum clinical translation

Cell and Gene Therapy Bioprocessing:

  • Build a strategy for monitoring quality across your process with PAT and automated analytics
  • Get to grips with technologies and novel platforms for efficient upstream and downstream processes
  • Simplify manufacturing automation and prepare for commercialization

Cell and Gene Therapy Commercialisation:

  • Work towards CART 3.0 with off the shelf technology platforms and novel CARs
  • Optimise your strategy to deliver an economically viable manufacturing journey
  • Ensure profitability with forward thinking in facility design and scalability strategies

Supply Chain Barriers: Upstream and Downstream Considerations

  • Improve confidence in your raw material supply chain – vectors, risk mitigation and more
  • Stay up to date on cryo considerations when moving from clinical to commercial phase manufacturing
  • Prepare for successful delivery to patients & supply chain scale up

Cell and Gene Therapy Connect – Partnering Track

  • Keep abreast of the evolving landscape of cell and gene therapies
  • Tackle collaboration – new outsourcing models, when to make the decision to ‘spin out’ and more
  • Dive into pharmacoeconomic approaches to reimbursement

As an official media partner, Biotechnology Community would like to give all members 25% off conference passes* Get your discount


We are happy to announce that we will be joining the event and are excited to meet you there! A post-write-up article about the congress will be up afterwards, stay tuned!